I: Immunosuppressants, Neurologic Disorders, and Neuroprotection.- 1 Introduction: Immunosuppressants as Neuroprotective Agents.- II: Immunosuppressants and Parkinsons Disease.- 2 Cyclosporin-Mediated Amelioration of Degeneration of Dopaminergic Neurons in Experimental Models of Parkinsonism.- 3 Immunophilin Ligands and Dopamine Neurons: Specific Effects in Culture and In Vivo.- 4 Effects of Neuroimmunophilin Ligands on Parkinsons Disease and Cognition.- 5 Improved Survival of Grafted Dopamine Neurons by Calcineurin Inhibitors.- 6 Possible Mechanisms Underlying the Protective Action of Immunosuppressants Against Parkinsons Disease: The Mitochondrial Permeability Transition Pore Hypothesis.- III: Immunosuppressants and other Age-Related Disorders.- 7 Immunosuppressants and Alzheimers Disease.- 8 Cyclosporin A Protects Striatal Neurons from Mitochondrial Dysfunction: Implications for Huntingtons Disease.- IV: Immunosuppressants, Stroke, and Traumatic Brain Injury.- 9 Cyclosporin A Protects Mitochondria in an In Vitro Model of Hypoxia/Reperfusion Injury.- 10 Protective Effect of Cyclosporin A on Glial Activation and White Matter Alterations Induced by Chronic Cerebral Hypoperfusion.- 11 Blockade of Late-Onset Reduction of Muscarinic Acetylcholine Receptors by Immunosuppressants in Forebrain Ischemia.- 12 The Role of Immunophilins in Focal Cerebral Ischemia: Evidence of Neuroprotection by FK506.- 13 Immunosuppressants in Traumatic Brain Injury.- V: Immunosuppressants and Spinal Cord Injury.- 14 Inhibition of Lipid Peroxidation by Cyclosporin After Spinal Cord Injury in Rats.- 15 Axonal Regeneration in Cyclosporin A-Treated Rats Submitted to Transverse Section of the Spinal Cord.- VI:Immunosuppressants and Sciatic Nerve Injury.- 16 Neuroimmunophilin Ligands Accelerate and Promote Nerve Regeneration in the Rat Peripheral Nerve and Spinal Cord: Role of the Steroid ReceptorFKBP52 Complex.- 17 Neuroimmunophilin Ligands Stimulate Recovel³'